Stearns K, Goetinck P F
J Cell Physiol. 1979 Jul;100(1):33-8. doi: 10.1002/jcp.1041000104.
The potential of nanomelic chondrocytes to synthesize chondroitin sulfate was investigated by providing the mutant cells with p-nitrophenyl-beta-D-xyloside, a compound which acts as an artificial acceptor for glycosaminoglycan synthesis. Under these conditions the synthesis of chondroitin sulfate in nanomelic and normal chondrocytes is comparable. The chondroitin sulfate synthesized by the mutant is indistinguishable in molecular size and composition from that synthesized by similarly treated normal chondrocytes.
通过给突变细胞提供对硝基苯基-β-D-木糖苷(一种作为糖胺聚糖合成人工受体的化合物),研究了纳米肢软骨细胞合成硫酸软骨素的潜力。在这些条件下,纳米肢软骨细胞和正常软骨细胞中硫酸软骨素的合成情况相当。突变细胞合成的硫酸软骨素在分子大小和组成上与经类似处理的正常软骨细胞合成的硫酸软骨素无法区分。